OrbiMed is the world’s largest healthcare-dedicated investment firm, with over $5 billion in assets under management.

healthy eating

OrbiMed’s investment business, founded in 1989, invests across the spectrum of healthcare companies – from private start-ups to large multinational companies.

The company manages a family of healthcare-focused investment funds including the Caduceus Capital hedge fund, two investment trusts listed on the London Stock Exchange (the Finsbury Worldwide Pharmaceutical Trust and the Biotechnology Growth Trust) and a family of global venture capital funds.

OrbiMed’s investment team includes over 30

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@risk.net or view our subscription options here: http://subscriptions.risk.net/subscribe

You are currently unable to copy this content. Please contact info@risk.net to find out more.

Sorry, our subscription options are not loading right now

Please try again later. Get in touch with our customer services team if this issue persists.

New to Risk.net? View our subscription options


Want to know what’s included in our free membership? Click here

This address will be used to create your account

You need to sign in to use this feature. If you don’t have a Risk.net account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here